Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Clinical trial NCT01238055 · COMPLETED

Trial details

NCT number: NCT01238055
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Gastric Cancer

Start date: 2008-11-01
Primary completion: 2012-04-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.